Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.50)
# 245
Out of 5,182 analysts
563
Total ratings
51.94%
Success rate
22%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $20.29 | +82.36% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $16.92 | +18.20% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $2.41 | +107.47% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $578.54 | -13.58% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $178.96 | +8.40% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.90 | +51.90% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.10 | +350.98% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $89.87 | -33.23% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $22.02 | +45.32% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $444.28 | +23.80% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $153.40 | -21.77% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.69 | +373.37% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $6.07 | -67.05% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $38.71 | -9.58% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $10.61 | +31.95% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $35.86 | -2.40% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $5.80 | +141.38% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $53.22 | +40.92% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $19.81 | +91.82% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $11.55 | +116.45% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $20.16 | +58.73% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.67 | +210.24% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $21.64 | -26.06% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $11.00 | +118.18% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.19 | +276.18% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $129.53 | -70.66% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $130.81 | +28.43% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.68 | +310.45% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.20 | +92.31% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.39 | +197.70% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $28.78 | -30.51% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.99 | +503.02% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.85 | +168.04% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.42 | +30.64% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.13 | +348.34% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.06 | +1,315.09% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $26.19 | +33.64% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $10.02 | +648.50% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.76 | +153.62% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.25 | +703.21% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.53 | +28,255.39% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $14.55 | +312.37% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $1.79 | +737.99% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.94 | +4,150.80% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $20.29
Upside: +82.36%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $16.92
Upside: +18.20%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $2.41
Upside: +107.47%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $578.54
Upside: -13.58%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $178.96
Upside: +8.40%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.90
Upside: +51.90%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.10
Upside: +350.98%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $89.87
Upside: -33.23%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $22.02
Upside: +45.32%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $444.28
Upside: +23.80%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $153.40
Upside: -21.77%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.69
Upside: +373.37%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $6.07
Upside: -67.05%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $38.71
Upside: -9.58%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $10.61
Upside: +31.95%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $35.86
Upside: -2.40%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.80
Upside: +141.38%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $53.22
Upside: +40.92%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $19.81
Upside: +91.82%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $11.55
Upside: +116.45%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $20.16
Upside: +58.73%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $9.67
Upside: +210.24%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $21.64
Upside: -26.06%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $11.00
Upside: +118.18%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.19
Upside: +276.18%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $129.53
Upside: -70.66%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $130.81
Upside: +28.43%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.68
Upside: +310.45%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $5.20
Upside: +92.31%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.39
Upside: +197.70%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $28.78
Upside: -30.51%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.99
Upside: +503.02%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.85
Upside: +168.04%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.42
Upside: +30.64%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.13
Upside: +348.34%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.06
Upside: +1,315.09%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $26.19
Upside: +33.64%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $10.02
Upside: +648.50%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.76
Upside: +153.62%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.25
Upside: +703.21%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.53
Upside: +28,255.39%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $14.55
Upside: +312.37%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $1.79
Upside: +737.99%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.94
Upside: +4,150.80%